Bekkers R L M, Hanselaar A G J M, Melchers W J G, van Schaik J H M, Boonstra H, Massuger L F A G
Universitair Medisch Centrum St Radboud, Postbus 9101, 6500 HB Nijmegen.
Ned Tijdschr Geneeskd. 2003 Feb 15;147(7):302-6.
To determine the number interventions and outcomes in patients referred with two consecutive Pap 2 cervical smear results who were managed either by a wait-and-see policy or aggressively, and to determine whether triage with high-risk human papillomavirus (hr-HPV) detection, resulting in the referral of only hr-HPV positive patients, would lead to the detection of all patients with cervical intraepithelial neoplasia (CIN).
Retrospective comparison and retrospective cohort study.
282 patients referred in 1997/'99 with 2 consecutive Pap 2 cervical smears in the screening program were included. Patients referred to the UMC St Radboud Hospital (n = 140; mean age: 45 years) underwent a colposcopy during which only lesions suggestive for CIN 3 were treated. All other colposcopic lesions (CIN 2 or less) were not treated but followed prospectively. Patients referred to the Canisius Wilhelmina Hospital (CWZ) (n = 142; mean age: 44 years) underwent colposcopy during which all colposcopic lesions (including CIN 2 or less) were treated directly. The two groups were compared in terms of the final cytological follow-up, the number of loop excisions, and the number of patients with CIN. The mean follow up was 40 months. In the first group, the effect of triage using hr-HPV detection was also investigated retrospectively.
With the wait-and-see approach, statistically significantly fewer diathermic loop excisions were done: 13 versus 124. After the follow-up period there was no statistically significant difference between the two groups in terms of the number of patients with persisting Pap 2: 16 (11%) versus 12 (8%). Triage with hr-HPV detection would identify all patients with CIN 3, 50% of the patients with CIN 2, and none of the patients with CIN 1; of the 48 hr-HPV-positive women, 1 had a CIN 3 lesion and 3 had a CIN 2 lesion; of the remaining 92 women, 2 had a CIN 1 lesion and 3 had a CIN 2 lesion.
The wait-and-see approach led to fewer interventions, while the number of women with persisting Pap 2 smears was not higher than with the aggressive approach. Triage with hr-HPV may reduce the number of referrals and colposcopies, but follow-up remains necessary in all women regardless of hr-HPV status.
确定连续两次巴氏2级宫颈涂片检查结果异常且采用观察等待策略或积极治疗策略的患者的干预措施数量和结局,并确定通过检测高危型人乳头瘤病毒(hr-HPV)进行分流,即仅转诊hr-HPV阳性患者,是否能检测出所有宫颈上皮内瘤变(CIN)患者。
回顾性比较和回顾性队列研究。
纳入1997年/1999年筛查项目中连续两次巴氏2级宫颈涂片检查结果异常而转诊的282例患者。转诊至圣拉德波德大学医学中心(UMC)医院(n = 140;平均年龄:45岁)的患者接受了阴道镜检查,期间仅对疑似CIN 3的病变进行治疗。所有其他阴道镜检查病变(CIN 2或更低级别)未治疗,但进行前瞻性随访。转诊至卡尼修斯·威廉明娜医院(CWZ)(n = 142;平均年龄:44岁)的患者接受了阴道镜检查,期间所有阴道镜检查病变(包括CIN 2或更低级别)均直接进行治疗。比较两组的最终细胞学随访结果、环形切除术数量以及CIN患者数量。平均随访时间为40个月。在第一组中,还回顾性研究了使用hr-HPV检测进行分流的效果。
采用观察等待方法,进行的透热环形切除术在统计学上显著更少:13例对124例。随访期结束后,两组在持续巴氏2级涂片的患者数量方面无统计学显著差异:16例(11%)对12例(8%)。通过hr-HPV检测进行分流可识别所有CIN 3患者、50%的CIN 2患者,而无法识别CIN 1患者;在48例hr-HPV阳性女性中,1例有CIN 3病变,3例有CIN 2病变;在其余92例女性中,2例有CIN 1病变,3例有CIN 2病变。
观察等待方法导致的干预措施更少,而持续巴氏2级涂片的女性数量并不高于积极治疗方法。通过hr-HPV进行分流可能会减少转诊和阴道镜检查的数量,但无论hr-HPV状态如何,所有女性都仍需进行随访。